middle.news
Percheron Therapeutics Secures $2.2M to Fuel HMBD-002 Phase II Progress
1:24pm on Tuesday 14th of April, 2026 AEST
•
Biotechnology
Read Story
Percheron Therapeutics Secures $2.2M to Fuel HMBD-002 Phase II Progress
1:24pm on Tuesday 14th of April, 2026 AEST
Key Points
Completed 2 for 5 entitlement offer raising $2.2 million
Funds to support HMBD-002 phase II trial planned for 2026
Includes new shares and free attaching options exercisable at $0.01
Strong participation from existing and new shareholders
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Percheron Therapeutics (ASX:PER)
OPEN ARTICLE